We assessed the clinical manifestations in upper and lower limb deep venous thrombosis patients from India and difference in etiological factors. Fifty-three patients with primary upper extremity deep vein thrombosis (UEDVT; males 30, females 23) and 236 patients with lower limb deep vein thrombosis (LLDVT; males 157, females 79) were included in this study. The thrombophilia markers studied were protein C (PC), protein S (PS), antithrombin (AT) III, and factor V Leiden (FVL) mutation. Females had significantly higher prevalence of prothrombotic markers as compared to males (P ¼ .046) in the UEDVT group. No statistically significant differences in the prevalence of prothrombotic markers were observed between the LLDVT and the UEDVT patients. The clinical picture however revealed greater involvement of thrombus of the iliofemoral vein (P ¼ .009) and the proximal tibial vein (P ¼ .005) in males than females, while no differences were observed in the clinical manifestations between the 2 sexes in UEDVT patients. Our study is able to give a broad perspective of the prevalence data of UEDVT and LLDVT in the city of Mumbai of approximately 5 million population served by this hospital. We conclude that the topology of thrombosis in deep vein thrombosis (DVT) patients in India is different from that of the Western countries.
Introduction
The etiology of lower limb deep venous thrombosis (LLDVT) and upper extremity deep venous thrombosis (UEDVT) is multifactorial. The anatomical predisposition is also different among the 2 limbs. The known extrinsic causes of UEDVT are catheter insertion, malignancy, arm surgery, or immobilization, whereas hip surgery, pregnancy, or long haul flights termed the economy class syndrome are implicated as the causal factors in LLDVT. In spite of high prevalence of thrombophilia markers in Caucasian population, 1, 2 Western literature has conflicting reports on the role of thrombophilia in these 2 groups. 3, 4 Various centers in the West have now resorted to pooling data or maintaining a registry to get a higher population number and find causative factors for both UEDVT and LLDVT. In India, there is no accurate data of the prevalence of deep vein thrombosis (DVT) and the role of thrombophilia markers in both UEDVT and LLDVT, except for 1 small study by Agrawal et al 5 that linked activated protein C (APC) resistance to LLDVT. Because of this lacuna, Indian clinicians often have to refer to Western literature. The findings from Caucasian population cannot be extrapolated to Asian population, as the prevalence of prothrombotic markers is different. The current study was undertaken study was to compare the prevalence of thrombophilia markers in Indian UEDVT and LLDVT patients. In addition, we also tried to gauge the difference in clinical severity between the 2 sexes in the LLDVT group.
Materials and Methods
Fifty-three patients with primary UEDVT (males 30, females 23; mean age + SD 31.98 + 15.89 years) and 236 patients with LLDVT (males 157, females 79; mean age 35.58 + 13.48 years) referred to our center between April 1999 and April 2009, for thrombophilia testing after the first episode of thrombosis were included in the current study. None of the patients included in the present analysis had any of the known acquired risk factors at the time of initial presentation. The thrombophilia markers studied were protein C (PC), protein S (PS), antithrombin (AT), and factor V Leiden (FVL) mutation. We did not study prothrombin gene polymorphism as it is absent in Indian population. 6 
Results
Overall, 39.62% of the UEDVT patients were positive for any of the 4 thrombophilia markers studied as against 41.52% in the LLDVT group (P ¼ .8; Table 1 ). Females had significantly higher prevalence of prothrombotic markers as compared to males (P ¼ .046) in the UEDVT group. No statistically significant differences in the prevalence of prothrombotic markers were observed between males and females in LLDVT group (P ¼ .16).
We retrospectively carried out analysis of clinical data of patients with objectively confirmed DVT of lower limb (first episode) who were worked up for thrombophilia reported to our center during the last 10 years. The patient population consisted of 157 males and 79 females with a mean age of 35 years, respectively. Our group had twice the number of males being admitted with objectively confirmed DVT. Further analysis showed that the manifestation of thrombosis was more in the left leg in both the sexes, but there was no statistically significant difference between the 2 sexes ( Table 2 ). The clinical picture however revealed greater involvement of thrombus of the iliofemoral vein (P ¼ .009) and the proximal tibial vein (P ¼ .005) in males than in females. No significant differences of the prevalence of prothrombotic markers between the 2 sexes (P ¼ .28) were observed. When stratified, based on the presence of abnormal thrombophilia markers, the data showed no statistically significant difference in the clinical manifestations between the 2 sexes.
Discussion
The current study showed no difference in the prevalence of the common heritable thrombophilia markers between UEDVT and LL DVT patients, though the association was much stronger in females than in males with UEDVT. Approximately one third of our patients in both the groups could be explained by any of the 4 common heritable thrombophilia markers studied. The greater involvement of thrombus in the disease pathology in males in the LLDVT group in our study could be attributed to several reasons. Our center caters to lower strata of society, where majority of the females usually do household work and are physically very active. Furthermore, the use of oral contraceptives, smoking, and drinking that are known to be risk factors for thrombosis are not common in Indian women. A few recent studies in mice have shown that the difference in growth hormone release between males and females plays an important role in thrombus formation. 7 Our study is able to give a broad perspective of the prevalence of UEDVT and LLDVT in the city of Mumbai. The analysis included 236 patients with LLDVT of approximately 5 million patients attending the outpatient departments of the hospital over last 10 years, which works out to be 44.6 cases per million per year. If another 53 patients are added with upper limb DVT, the total prevalence of DVT in our population becomes approximately 55 per million patients per year as against 1200 per million in the general population in Western countries. 1 However, our data refer to spontaneous DVT in the patients without any apparent external predisposition. We have excluded patients who were admitted during nonworking hours and had already been on anticoagulation, but this number was not very significant. The overall low prevalence of DVT in our country may be attributed to several factors-differences in the lifestyle (diet rich in carbohydrates, strenuous physical activity devoid of the stress of modern day living), higher prevalence of prothrombotic markers in Caucasian population than Asians. 8 As India industrializes, and more women join the work force usually in the service sector, whether the change in the lifestyle will make them more prone to thrombosis as their Western counterparts needs to be seen. 
